Key Products: ARD-101, oral, gut-restricted small-molecule TAS2R agonist
For individuals hesitant about needles or the logistics of injectable medication, the oral option with comparable outcomes provides a meaningful alternative
Potential benefits include reduced steroid dependence, fewer hospitalizations, and improved durability of advanced therapy
As of December 2024, the FDA approved tirzepatide for treatment of moderate-to-severe obstructive sleep apnea (OSA) in patients with obesity based on the results of two trials
Calculator Mechanics Our liposuction financing calculator converts a procedure price into realistic monthly payments and a transparent total cost
Green P et al, Navigating large-volume subcutaneous injections of biopharmaceuticals: a systematic review of clinical pipelines and approved products